BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 27 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $101,000 | +9.8% | 17,900 | +12.6% | 0.01% | 0.0% |
Q2 2022 | $92,000 | -34.8% | 15,900 | +14.4% | 0.01% | -20.0% |
Q1 2022 | $141,000 | -25.8% | 13,900 | -39.3% | 0.01% | -28.6% |
Q4 2021 | $190,000 | +21.0% | 22,900 | +18.0% | 0.01% | -36.4% |
Q3 2021 | $157,000 | – | 19,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynwood Capital Management Inc. | 1,198,000 | $6,733,000 | 7.35% |
K.J. Harrison & Partners Inc | 479,838 | $2,748,000 | 0.97% |
SABBY MANAGEMENT, LLC | 94,005 | $528,000 | 0.67% |
Redmond Asset Management, LLC | 137,689 | $774,000 | 0.29% |
Concord Wealth Partners | 17,775 | $100,000 | 0.03% |
Virtu Financial LLC | 48,347 | $272,000 | 0.02% |
Caption Management, LLC | 177,000 | $996,000 | 0.01% |
WASATCH ADVISORS LP | 353,744 | $1,988,000 | 0.01% |
Summit Trail Advisors, LLC | 35,000 | $197,000 | 0.01% |
BLUEFIN CAPITAL MANAGEMENT, LLC | 17,546 | $99,000 | 0.01% |